Publicaciones (37) Publicaciones de MARÍA ESTHER MANCEBO SIERRA

2024

  1. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  3. Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study

    Andrology, Vol. 11, Núm. 1, pp. 24-31

  4. Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

    Frontiers in Pediatrics, Vol. 10

  5. Tryptophan Modulation in Cancer-Associated Cachexia Mouse Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 16

2022

  1. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

    Biomedicines, Vol. 10, Núm. 2

  2. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19

    Scientific reports, Vol. 12, Núm. 1, pp. 10369

  5. Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional Study

    Methods and Protocols, Vol. 5, Núm. 5

  6. Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities

    Immunity and Ageing, Vol. 19, Núm. 1

2021

  1. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

  2. Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1229-1235

  3. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2020

  1. Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft

    Kidney International, Vol. 98, Núm. 3, pp. 732-743

  2. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients – a single centre cohort study

    Transplant International, Vol. 33, Núm. 4, pp. 402-413

2019

  1. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation

    Frontiers in Immunology, Vol. 10

2018

  1. Donor-Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching

    Liver Transplantation, Vol. 24, Núm. 12, pp. 1726-1735

2017

  1. 5-gene differential expression predicts stability of human intestinal allografts

    Experimental and Molecular Pathology, Vol. 103, Núm. 2, pp. 163-171